Product NDC: | 0942-0641 |
Proprietary Name: | ACD-A |
Non Proprietary Name: | Anticoagulant Citrate Dextrose Solution Formula A |
Active Ingredient(s): | 3.65; 12.25; 11 g/500mL; g/500mL; g/500mL & nbsp; Anticoagulant Citrate Dextrose Solution Formula A |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0942-0641 |
Labeler Name: | Fenwal Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BN160918 |
Marketing Category: | NDA |
Start Marketing Date: | 20070301 |
Package NDC: | 0942-0641-04 |
Package Description: | 1000 mL in 1 BAG (0942-0641-04) |
NDC Code | 0942-0641-04 |
Proprietary Name | ACD-A |
Package Description | 1000 mL in 1 BAG (0942-0641-04) |
Product NDC | 0942-0641 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Anticoagulant Citrate Dextrose Solution Formula A |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20070301 |
Marketing Category Name | NDA |
Labeler Name | Fenwal Inc |
Substance Name | ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM CITRATE |
Strength Number | 3.65; 12.25; 11 |
Strength Unit | g/500mL; g/500mL; g/500mL |
Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |